Quality of evidence-based guidelines for platelet transfusion and use: A systematic review.
AGREE II
evidence-based guidelines
platelet transfusion
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
revised:
02
12
2020
received:
04
09
2020
accepted:
04
12
2020
pubmed:
24
1
2021
medline:
15
7
2021
entrez:
23
1
2021
Statut:
ppublish
Résumé
Guidelines for platelet (PLT) transfusion are an important source of information for clinicians. Although guidelines intend to increase consistency and quality of care, variation in methodology and recommendations may exist that could impact the value of a guideline. We aimed to determine the quality of existing PLT transfusion guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument and to describe the inconsistencies in recommendations. A systematic search was undertaken for evidence-based guidelines from January 1, 2013, to January 25, 2019. Citations were reviewed in duplicate for inclusion and descriptive data extracted. Four physicians appraised the guideline using the AGREE II instrument and the scaled score for each item evaluated was calculated. The protocol was registered in PROSPERO. Of 6744 citations, 6740 records were screened. Seven of 28 full-text studies met the inclusion criteria. The median scaled score (and the interquartile range of the scaled score) for the following items were as follows: scope and purpose, 94% (8%); stakeholder involvement, 63% (18%); rigor of development, 83% (14%); clarity of presentation, 94% (6%); applicability, 58% (20%); and editorial independence, 77% (4%). Overall quality ranged from 4 to 7 (7 is the maximum score). Inconsistent recommendations were on prophylactic PLT transfusion in hypoproliferative thrombocytopenia in the presence of risk factors and dose recommendations. Inconsistencies between guidelines and variable quality highlight areas for future guideline writers to address. Areas of specific attention include issues of stakeholder involvement and applicability.
Sections du résumé
BACKGROUND
Guidelines for platelet (PLT) transfusion are an important source of information for clinicians. Although guidelines intend to increase consistency and quality of care, variation in methodology and recommendations may exist that could impact the value of a guideline. We aimed to determine the quality of existing PLT transfusion guidelines using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument and to describe the inconsistencies in recommendations.
STUDY DESIGN AND METHODS
A systematic search was undertaken for evidence-based guidelines from January 1, 2013, to January 25, 2019. Citations were reviewed in duplicate for inclusion and descriptive data extracted. Four physicians appraised the guideline using the AGREE II instrument and the scaled score for each item evaluated was calculated. The protocol was registered in PROSPERO.
RESULTS
Of 6744 citations, 6740 records were screened. Seven of 28 full-text studies met the inclusion criteria. The median scaled score (and the interquartile range of the scaled score) for the following items were as follows: scope and purpose, 94% (8%); stakeholder involvement, 63% (18%); rigor of development, 83% (14%); clarity of presentation, 94% (6%); applicability, 58% (20%); and editorial independence, 77% (4%). Overall quality ranged from 4 to 7 (7 is the maximum score). Inconsistent recommendations were on prophylactic PLT transfusion in hypoproliferative thrombocytopenia in the presence of risk factors and dose recommendations.
CONCLUSION
Inconsistencies between guidelines and variable quality highlight areas for future guideline writers to address. Areas of specific attention include issues of stakeholder involvement and applicability.
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
948-958Informations de copyright
© 2021 AABB.
Références
Lohr KN, Field MJ. Clinical Practice Guidelines: Directions for a New Program. Vol 90. Washington, DC: National Academies Press, 1990.
Culleton B. Development and limitations of clinical practice guidelines. P. Parfrey B. Barrett, (ed.). Clinical Epidemiology. New York, NY: Springer, 2008; p. 251-261.
Vernooij RW, Sanabria AJ, Solà I, Alonso-Coello P, García LM. Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks. Implement Sci. 2014;9(1):3.
Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;355(9198):103-106.
Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines?: The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999;281(20):1900-1905.
Gottschall J, Wu Y, Triulzi D, et al. The epidemiology of platelet transfusions: an analysis of platelet use at 12 US hospitals. Transfusion. 2020;60(1):46-53.
Etchells M, Spradbrow J, Cohen R, et al. Audit of appropriate use of platelet transfusions: Validation of adjudication criteria. Vox Sang. 2018;113(1):40-50. https://doi.org/10.1111/vox.12550.
Qureshi H, Lowe D, Dobson P, et al. National comparative audit of the use of platelet transfusions in the UK. Transfus Clin Biol. 2007;14(6):509-513.
Metz J, McGrath KM, Copperchini ML, et al. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma: an audit in a tertiary care teaching hospital. Med J Aust. 1995;162(11):572-577.
Curley A, Stanworth SJ, Willoughby K, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380(3):242-251.
Baharoglu MI, Cordonnier C, Salman RA-S, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605-2613.
Pavenski K, Stanworth S, Fung M, et al. Quality of evidence-based guidelines for transfusion of red blood cells and plasma: A systematic review. Transfus Med Rev. 2018;32(3):135-143.
Nahirniak S, Slichter SJ, Tanael S, et al. Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia. Transfus Med Rev. 2015;29(1):3-13.
Brouwers MC, Kho ME, Browman GP, et al. AGREE II: Advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839-E842.
Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 1: Performance, usefulness and areas for improvement. CMAJ. 2010;182(10):1045-1052.
Brouwers MC, Kho ME, Browman GP, et al. Development of the AGREE II, part 2: Assessment of validity of items and tools to support application. CMAJ. 2010;182(10):E472-E478.
AGREE Next Steps Consortium (2017). The AGREE II Instrument [Electronic version]. 2017.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-e34.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-1012. https://doi.org/10.1016/j.jclinepi.2009.06.005.
Arwa Z. Al-Riyami JD, Jug R, et al. Quality of evidence-based guidelines for transfusion of platelets: A systematic review. PROSPERO 2019 CRD42019139312. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019139312 2019.
Google Translate Module. [cited 2019 Aug 21]. Available from: https://translate.google.com/#view=home&op=docs&sl=auto&tl=en.
Schiffer CA, Bohlke K, Anderson KC. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update summary. J Oncol Pract. 2018;14(2):129-133.
Estcourt L, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions. Br J Haematol. 2016;176(3):365-394.
Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: A clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205-213.
New HV, Berryman J, Bolton-Maggs PH, et al. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016;175(5):784-828.
Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187-207.
Harrison P, Subcommitte on Platelet Physiology. The use of platelets in regenerative medicine and proposal for a new classification system: Guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1895-1900.
Kumar A, Mhaskar R, Grossman BJ, et al. Platelet transfusion: A systematic review of the clinical evidence. Transfusion. 2015;55(5):1116-1127.
al-Riyami A, Haynes LG, Campbell AM. The construction of a monoclonal diagnostic system for the field detection of Vibrio cholerae. FEMS Microbiol Immunol. 1991;3(1):25-31.
Kaufman RM, Assmann SF, Triulzi DJ, et al. Transfusion-related adverse events in the Platelet Dose study. Transfusion. 2015;55(1):144-153.
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ. 1999;318(7183):593-596.
Dixon C, Dixon PE, Sultan S, et al. Guideline developers in the United States were inconsistent in applying criteria for appropriate GRADE use. J Clin Epidemiol. 2020;124:193-199.
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530.
Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D. A systematic review of appraisal tools for clinical practice guidelines: Multiple similarities and one common deficit. International J Qual Health Care. 2005;17(3):235-242. https://doi.org/10.1093/intqhc/mzi027.
Hoffmann-Eßer W, Siering U, Neugebauer EA, Brockhaus AC, McGauran N, Eikermann M. Guideline appraisal with AGREE II: Online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use. BMC Health Serv Res. 2018;18(1):143.
AGREE-REX Research Team (2019). The Appraisal of Guidelines Research & Evaluation-Recommendation EXcellence (AGREE-REX) [Electronic version]. Canada: AGREE-REX Research Team. Accessed August 17, 2020.
Brouwers MC, Spithoff K, Lavis J, Kho ME, Makarski J, Flórez ID. What to do with all the AGREEs? The agree portfolio of tools to support the guideline enterprise. J Clin Epidemiol. 2020;125:191-197.
Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care. 1986;2(1):53-63.
Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2004;44(1):10-15. https://doi.org/10.1046/j.0041-1132.2003.00518.x.